Results 1 - 20 of 46 in Interlace Medical
They currently have a $24.00 price target on the stock, down from their previous price target of $26.00. Several other analysts have also recently commented on the stock. Comment?
Hologic , a manufacturer of diagnostics products, medical imaging systems and surgical products has appointed Scott T. Garrett to the Company's newly expanded board of directors. Comment?
I have no qualms with those who believe it is the responsibility of the management of public companies to communicate clearly and accurately with investors about the current state of the business and the likely near-term conditions. Comment?
Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Hologic Inc. Comment?
The firm currently has a "buy" rating on the stock. A number of other firms have also recently commented on HOLX. Comment?
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Hologic, Inc. Comment?
Hologic updated its FY13 earnings guidance on Monday. The company provided earnings per share guidance of $1.54-1.56 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.58, AnalystRatingsNetwork.com reports. Comment?
Hologic announced its earnings results on Monday. The company reported $0.35 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.34 by $0.01, Stock Ratings Network reports. Comment?
Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Novadaq Technologies Inc. Comment?
... of global surgical marketing, she led a direct-to-consumer advertising campaign and the integration of Interlace Medical, acquired by Hologic in 2012. "Shacey has incredible execution skills and a proven ability to grow product lines and lead top ... Comment?
The firm issued a hold rating on the stock. HOLX has been the subject of a number of other recent research reports. Comment?
Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Exide Technologies , Hologic Inc. Comment?
This year, Hologic Inc. expects to fork over about $25 million under a new federal excise tax on medical devices to support ObamaCare. Comment?
Bedford, Mass.-based medical imaging and diagnostic test company, Hologic Inc. completed the sale of its LIFECODES business unit to Georgia-based Immucor, a blood transfusion technology manufacturer. Comment?
Hologic's focus on women's health is unmatched. Founded in 1985, Hologic, Inc. has grown to become a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products created specifically to address the healthcare needs of women throughout the world. Comment?
DiagnoCure is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. Comment?
Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:- Hologic, Inc. Comment?
The Corporation will also provide a live webcast of the call. Interested participants may access the webcast on DiagnoCure's website at www.diagnocure.com , through a link on the Investors page - Presentations. Comment?
Hologic, Inc. , a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will display an extensive suite of healthcare solutions for breast cancer screening and diagnosis, breast biopsy, osteoporosis risk assessment, medical MRI ... (more) Comment?
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems, and surgical products dedicated to serving the healthcare needs of women throughout the world. Comment?